The accumulation of experimental proofs in animal models indicate that pharmacological interference with some effectors (such as microglia, VEGF/Ang, complement pathway inhibitors, and visual cycle inhibitors) can ameliorate or delay retinal disease [375]. This evidence concerns the gene VEGFA and Abnormal retinal morphology.